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ABSTRACT 
The Anti-inflammatory activity of JOINTS KARE, a poly herbal ayurvedic formulation 
developed and studied in the Jammu Institute of Ayurveda and Research Pharmacy with 
the technical assistance from Indian Institute of Integrative Medicine, the study was 
performed on albino rats of carrageenan induced model. 20 healthy albino rats were 
selected randomly and divided into five groups. The inflammatory reaction is readily 
produced in rats in the form of paw oedema with the help of irritants. Here the rats of 
treated Group II, III, IV and V were administered orally with Ibuprofen solution, Joints Kare 
125mg/Kg Body wt, Joints Kare 250mg/Kg Body wt, Joints Kare 500mg/Kg Body wt, 
respectively one hour before injecting 1% w/v suspension of carrageenan (0.1 ml) into the 
sub plantar region of left hind paw of all the five groups.  
Paw volume of all 20 rats were measured soon after injecting carrageenan. The 
volume was again measured after 1, 2, 3, 4 & 24 hrs in all the five groups of rats. The 
change in paw volume of Group I was compared with Group II, III, IV & V. Also the treated 
Group II, III, IV, V were also compared in between and expressed as percentage oedema 
inhibition by the drug. Results of the present study are based on the oedema of hind paw of 
rats of all five groups measured after 1hr, 2hrs, 3hrs, 4hrs and 24hrs after carrageenan 
injection. The maximum activity of all trial Groups were observed during first and second 
hr. and the results are significant (P <0.005) and are comparable to standard Ibuprofen. 
Highest percentage oedema Inhibition was seen after 1 & 2 hrs. Summarizing the above it 
is concluded that Joints Kare has showed its extreme utility or significance on the 
inflammation probably because of its excellent activity of inhibiting the both early released 
and late released mediators which is rarely seen in any anti-inflammatory formulation. 
KEYWORDS: Joints Kare, Polyherbal Formulation, Anti-Inflammatory Activity. 
INTRODUCTION
Inflammation is very normal effect in the 
body to rid the body of all its ill effects, our body 
creates inflammation under different situations, as 
soon as it has done its share of work, the body 
produces anti-inflammatory process and 
inflammation settles down. In normal healthy 
person this process is in perfect balance, however 
where there is an imbalance our body does not 
stop producing inflammation, instead 
inflammation will often simmer for long time and 
turning into a serious problems. The newer 
concept of the anti-inflammatory therapy 
originated with the discovery of salicylates from 
the plant source in the mid eighteenth century, 
when Reverend Edmound Stone, in England, 
accidentally tasted the bark of the common 
willow, Salix alba vulgaris. The active ingredient in 
this was a bitter glycoside Salicin which was first 
isolated in pure form by Leroux in 1829, who 
evaluated its antipyretic activity also later on 
plenty of Anti-inflammatory were discovered but 
having serious side effects.  
There are millions of people around the 
world is affecting with this pathological condition 
and are totally dependent on multiple of anti-
inflammatory drugs, which are abundantly 
available in modern medical science, but with 
maximum side effects and complications1. On an 
average 1 in 1200 patients taking NSAIDs for at 
least two months die from Gastrodudenal 
complications who would not have died had they 
not taken NSAIDs2. Similarly eight to ten percent 
of the 50,000 annual kidney failures in the United 
States are caused by Acetaminophen3. So 
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development of a new Ayurvedic anti-
inflammatory agent is the present day need in the 
world which has gathered momentum from the 
last two decades because of the fact that currently 
available synthetic drugs show side effects as 
mentioned above. 
MATERIALS AND METHODS  
This Study was performed on albino rats 
of carrageenan induced model for evaluating its 
Anti-inflammatory activity4, twenty healthy albino 
rats were selected randomly and divided into five 
groups for the experimental study to evaluate the 
anti-inflammatory activity of different doses of 
Joints Kare poly herbal formulation. Animals were 
divided into five groups each group containing 
four rats, which are kept in separate cages and 
labeled as 
Group I - control, placebo given-saline water 
(1ml/100gm Body wt.),  
Group II - Standard, Medicine given Ibuprofen Sol. 
(100mg/Kg Body wt.) 
Group III – Trial, Joints Kare will be given. 
(125mg/Kg Body wt) 
Group IV – Trial, Joints Kare will be given. 
(250mg/Kg Body wt) 
Group V – Trial, Joints Kare will be given. 
(500mg/Kg Body wt) 
The inflammatory reaction is readily 
produced in rats in the form of paw oedema with 
the help of irritant Carrageenan. Here the rats of 
treated Group II, III, IV, V are administered orally 
with drugs as mentioned above in the table before 
one hour injecting 1% w/v suspension of 
carrageenan (0.1 ml).  
Paw volume of all rats were measured 
soon after injecting carrageenan. The volume was 
again measured after 1, 2, 3, 4 & 24 hrs in all the 
groups of rats. The change in paw volume of 
Group I was compared with Group II, III, IV & V 
Group. Also the treated Group II, III, IV, V were 
also compared in between and expressed as 
percentage oedema inhibition by the drug.  
RESULTS AND DISCUSSION 
The result of the present study are based 
on the oedma of hind paw of rats of all five groups 
measured after 1hr,2hrs,3hrs,4hrs and 24hrs after 
administration of Carrageenin Injection. 
Table 1: Showing data of Anti-inflammatory activity after 1 hr of carrageenin Inj. 
S. No Group 1 Body 
Wt 
Drug and Dose Initial paw 
volume ml 
Final paw 
volume ml 
Oedema 
Vol. ml 
Mean 
Oedema 
Vol. ml/SEM. 
% 
Inhibition 
1 Control 133gms Saline water 
1ml/100gm body 
Wt. 
0.7 1.8 1.1 - - 
2 Control 150gms Saline water 
1ml/100gm body 
Wt. 
0.8 1.8 1.0 - - 
3 Control 140gms Saline water 
1ml/100gm body 
Wt. 
0.6 1.3 0.7 - - 
4 Control 133gms Saline water 
1ml/100gm body 
Wt. 
0.8 1.6 0.8 0.9 +0.0912 0% 
 Group 2        
5 Standard 137gms Ibuprofen100mg/
Kg Body Wt. 
0.7 1.4 0.7 - - 
6 Standard 145gms Ibuprofen100mg/
Kg Body Wt. 
0.8 1.4 0.6 - - 
7 Standard 140gms Ibuprofen100mg/
Kg Body Wt. 
0.9 1.2 0.3 - - 
8 Standard 147gms Ibuprofen100mg/
Kg Body Wt. 
1.0 1.5 0.5 0.52+0.0853 42.22 % 
 Group 3        
9 Trial (A) 130gm JOINTS KARE 
125mg/Kg Body 
Wt. 
0.8 1.3 0.5 - - 
10 Trial (A) 135gm JOINTS KARE 
125mg/Kg Body 
Wt. 
0.7 1.3 0.6 - - 
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11 Trial (A) 148gm JOINTS KARE 
125mg/Kg Body 
Wt. 
0.9 1.4 0.5 - - 
12 Trial (A) 130gm JOINTS KARE 
125mg/Kg Body 
Wt. 
0.9 1.4 0.5 0.52+0.0250 42.2% 
 Group 4        
13 Trial (B) 135gm JOINTS KARE 
250mg/Kg Body 
Wt 
0.8 1.4 0.6 - - 
14 Trial (B) 140gm JOINTS KARE 
250mg/Kg Body 
Wt. 
0.8 1.1 0.3 - - 
15 Trial (B) 138gm JOINTS KARE 
250mg/Kg Body 
Wt. 
0.9 1.4 0.5 - - 
16 Trial (B) 140gm JOINTS KARE 
250mg/Kg Body 
Wt. 
0.9 1.6 0.7 0.52+0.0853 42.22% 
 Group 5        
17 Trial (C) 140gms JOINTS KARE 
500mg/Kg Body 
Wt. 
0.9 1.5 0.6 - - 
18 Trial (C) 140gms JOINTS KARE 
500mg/Kg Body 
Wt. 
0.7 1.2 0.5 - - 
19 Trial (C) 139gms JOINTS KARE 
500mg/Kg Body 
Wt. 
0.7 1.1 0.4 - - 
20 Trial (C) 136gms JOINTS KARE 
500mg/Kg Body 
Wt. 
0.7 1.0 0.3 0.45+0.0645 50.0% 
Table 2: Showing Summary of Data (after 1hr) 
Group N Mean (Oedema vol. ml) Std Dev SEM 
 1 4 0.9 0.1826 0.09129 
 2 4 0.525 0.1708 0.08539 
 3 4 0.525 0.05 0.025 
 4 4 0.525 0.1708 0.08539 
 5 4 0.45 0.1291 0.06455 
Table 3: Showing Intermediate calculation of Anova table (after 1 hr) 
 Source of Variation SS DF Variance Est (MS) 
Between Groups 0.513 4 0.1282 
Within Groups 0.3325 15 0.02217 
Total 0.8455 19  
                
 
    s2_bet       MSbet          0.1282 
     F  =                      =                  =                        =   5.789                  P = 0.005 
                 s2_wit       MSwit          0.02217 
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Table 4: Bonferroni : Showing comparison of each group with Control - 1st group. (after 1 hr) 
Comparison Difference of means t P<.05 
5 vs 1: 0.45 - 0.9 = -0.45 4.274 Yes 
3 vs 1: 0.525 - 0.9 = -0.375 3.562 Yes 
2 vs 1: 0.525 - 0.9 = -0.375 3.562 Yes 
4 vs 1: 0.525 - 0.9 = -0.375 3.562 Yes 
Degrees of freedom: 15 
It is evident from Table No 1 & Graph A, that the volume(ml) of Oedema in Group1 (Control ) is 
0.9+ 0.0912, Group 2 (Standard) 0.52+0.0853, Group 3 (Joints Kare125mg/Kg) 0.52+0.0250, Group 4 
(Joints Kare 250mg/Kg) 0.52+0.0853 and Group 5 (Joints Kare 500mg/Kg) 0.45+0.0645. The results are 
statistically significant by ANOVA test. When compared with control group all treatment groups showed 
more significant by multiple comparisons as mentioned above in Table – 4. 
Table 5: Showing data of Anti-inflammatory activity after 2 hrs of carrageenin Inj. 
S. No Group 1 Body 
Wt 
Drug and Dose Initial paw 
volume ml 
Final paw 
volume ml 
Oedema 
Vol. ml 
Mean Oedema 
Vol. ml/SEM. 
% 
Inhibition 
1 Control 133gms Saline water 
1ml/100gm body Wt. 
0.7 2.0 1.3 - - 
2 Control 150gms Saline water 
1ml/100gm body Wt. 
0.8 2.2 1.4 - - 
3 Control 140gms Saline water 
1ml/100gm body Wt. 
0.6 1.7 1.1 - - 
4 Control 133gms Saline water 
1ml/100gm body Wt. 
0.8 2.1 1.3 1.27+0.0629 0% 
 Group 2 
5 Standard 137gms Ibuprofen100mg/Kg 
Body Wt. 
0.7 1.6 0.9 - - 
6 Standard 145gms Ibuprofen100mg/Kg 
Body Wt. 
0.8 1.6 0.8 - - 
7 Standard 140gms Ibuprofen100mg/Kg 
Body Wt. 
0.9 1.3 0.4 - - 
8 Standard 147gms Ibuprofen100mg/Kg 
Body Wt. 
1.0 1.6 0.6 0.67+0.0750 47.24% 
 Group 3 
9 Trial (A) 130gm J.K 125mg/Kg Body Wt 0.8 1.9 1.1 - - 
10 Trial (A) 135gm J.K. 125mg/Kg Body Wt 0.8 1.3 0.5 - - 
11 Trial (A) 148gm J.K. 125mg/Kg Body Wt 0.9 1.8 0.9 - - 
12 Trial (A) 130gm J.K. 125mg/Kg Body Wt 0.9 2.2 1.3 0.95+0.1708 27.19% 
 Group 4 
13 Trial (B) 135gm J.K 250mg/Kg Body Wt 0.8 1.8 1.0 - - 
14 Trial (B) 140gm J.K 250mg/Kg Body Wt 0.7 1.5 0.8 - - 
15 Trial (B) 138gm J.K 250mg/Kg Body Wt 0.9 1.9 1.0 - - 
16 Trial (B) 140gm J.K 250mg/Kg Body Wt 0.9 1.6 0.7 0.875+0.075 31.49% 
 Group 5 
17 Trial (C) 140gms J.K 500mg/Kg Body Wt 0.9 1.6 0.7 - - 
18 Trial (C) 140gms J.K 500mg/Kg Body Wt 0.7 1.4 0.7 - - 
19 Trial (C) 139gms J.K 500mg/Kg Body Wt 0.7 1.1 0.4 - - 
20 Trial (C) 136gms J.K 500mg/Kg Body Wt 0.7 1.1 0.4 0.55+0.0866 56.69% 
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It is evident from Table No 5 and Graph C That the volume (ml) of Oedema in Group1 (Control ) is 
1.27+0.0629, Group2 (Standard) 0.67+0.0750, Group 3 (J.K. 125mg/Kg) 0.95+0.1708, Group 4 (J.K. 
250mg/Kg) 0.875+0.075 and Group 5 (J.K. 500mg/Kg) 0.55+0.0866. The results are statistically 
significant by ANOVA test. When compared with control group, Group 5 (J.K.500mg/Kg) and Group 2 
(Standard) showed more significant by multiple comparisons. 
It is evident from Table No 6 and Fig E That the volume(ml) of Oedema in Group1 (Control) is 
1.4+0.0408, Group2 (Standard) 0.85+0.1658, Group 3(J.K.125mg/Kg) 1.12+0.0478, Group 4 (J.K. 
250mg/Kg) 1.1+0.1080 and Group 5 (J.K. 500mg/Kg) 0.82+0.1031. The results are statistically significant 
by ANOVA test. When compared with control group, Group 5 (J.K.500mg/Kg) and Group 2 (Standard) 
showed more significant by multiple comparisons. 
Table 7: Showing data of Anti-inflammatory activity after 4 hrs of carrageenin Inj. 
  S. No Group 1 Body 
Wt 
Drug and Dose Initial paw 
volume ml 
Final paw 
volume 
ml 
Oedema 
Vol. ml 
MeanOedema 
Vol. ml/SEM. 
% 
Inhibition 
1 Control 133gms Saline water 
1ml/100gm body Wt. 
0.7 2.0 1.3 - - 
2 Control 150gms Saline water 
1ml/100gm body Wt. 
0.8 2.2 1.4 - - 
Table 6: Showing data of Anti-inflammatory activity after 3 hrs of carrageenin Inj. 
S. No Group 1 Body 
Wt 
Drug and Dose Initial 
paw 
volume 
ml 
Final paw 
volume 
ml 
Oedema 
Vol. ml 
Mean 
Oedema 
Vol. ml/SEM. 
% 
Inhibition 
1 Control 133gms Saline water 
1ml/100gm body Wt. 
0.7 2.1 1.4 - - 
2 Control 150gms Saline water 
1ml/100gm body Wt. 
0.8 2.3 1.5 - - 
3 Control 140gms Saline water 
1ml/100gm body Wt. 
0.6 2.0 1.4 - - 
4 Control 133gms Saline water 
1ml/100gm body Wt. 
0.8 2.1 1.3 1.4+0.0408 O% 
 Group 2 
5 Standard 137gms Ibuprofen100mg/Kg 
Body Wt. 
0.7 1.8 1.1 - - 
6 Standard 145gms Ibuprofen100mg/Kg 
Body Wt. 
0.8 1.9 1.1 - - 
7 Standard 140gms Ibuprofen100mg/Kg 
Body Wt. 
0.9 1.3 0.4 - - 
8 Standard 147gms Ibuprofen100mg/Kg 
Body Wt. 
1.0 1.8 0.8 0.85+0.1658 39.28% 
 Group 3 
9 Trial (A) 130gm J.K 125mg/Kg Body Wt 0.8 2.0 1.2 - - 
10 Trial (A) 135gm J.K 125mg/Kg Body Wt 0.7 1.8 1.1 - - 
11 Trial (A) 148gm J.K 125mg/Kg Body Wt 0.9 2.1 1.2 - - 
12 Trial (A) 130gm J.K 125mg/Kg Body Wt 0.9 1.9 1.0 1.12+0.0478 20% 
 Group 4 
13 Trial (B) 135gm J.K 250mg/Kg Body Wt 0.8 2.0 1.2 - - 
14 Trial (B) 140gm J.K 250mg/Kg Body Wt 0.8 1.6 0.8 - - 
15 Trial (B) 138gm J.K 250mg/Kg Body Wt 0.9 2.0 1.1 - - 
16 Trial (B) 140gm J.K 250mg/Kg Body Wt 0.9 2.2 1.3 1.1+0.1080 21.42% 
 Group 5 
17 Trial (C) 140gms J.K 500mg/Kg Body Wt 0.9 1.9 1.0 - - 
18 Trial (C) 140gms J.K 500mg/Kg Body Wt 0.7 1.7 1.0 - - 
19 Trial (C) 139gms J.K 500mg/Kg Body Wt 0.7 1.4 0.7 - - 
20 Trial (C) 136gms J.K 500mg/Kg Body Wt 0.7 1.3 0.6 0.82+0.1031 41.42% 
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3 Control 140gms Saline water 
1ml/100gm body Wt. 
0.6 1.9 1.3 - - 
4 Control 133gms Saline water 
1ml/100gm body Wt. 
0.8 2.0 1.2 1.3+0.04083 O% 
 Group 2 
5 Standard 137gms Ibuprofen100mg/Kg 
Body Wt. 
0.7 1.8 1.1 - - 
6 Standard 145gms Ibuprofen100mg/Kg 
Body Wt. 
 1.0 1.9 0.9 - - 
7 Standard 140gms Ibuprofen100mg/Kg 
Body Wt. 
0.9 1.2 0.3 - - 
8 Standard 147gms Ibuprofen100mg/Kg 
Body Wt. 
1.0 1.9 0.9 0.8+ 0.1732 38.46% 
 Group 3 
9 Trial (A) 130gm J.K. 125mg/Kg Body 
Wt 
0.8 1.8 1.0 - - 
10 Trial (A) 135gm J.K. 125mg/Kg Body 
Wt 
0.8 1.5 0.7 - - 
11 Trial (A) 148gm J.K. 125mg/Kg Body 
Wt 
0.9 1.9 1.0 - - 
12 Trial (A) 130gm J.K. 125mg/Kg Body 
Wt 
0.9 2.1 1.2 0.97+0.1031 25.38% 
 Group 4 
13 Trial (B) 135gm J.K. 250mg/Kg Body 
Wt 
0.8 1.8 1.0 - - 
14 Trial (B) 140gm J.K. 250mg/Kg Body 
Wt 
0.7 1.7 1.0 - - 
15 Trial (B) 138gm J.K. 250mg/Kg Body 
Wt 
0.9 1.8 0.9 - - 
16 Trial (B) 140gm J.K. 250mg/Kg Body 
Wt 
0.9 1.7 0.8 0.92+0.0478 29.22% 
 Group 5 
17 Trial (C) 140gms J.K. 500mg/Kg Body Wt 0.9 1.7 0.8 - - 
18 Trial (C) 140gms J.K. 500mg/Kg Body Wt 0.7 1.8 1.1 - - 
19 Trial (C) 139gms J.K. 500mg/Kg Body Wt 0.7 1.4 0.7 - - 
20 Trial (C) 136gms J.K. 500mg/Kg Body Wt 0.7 1.2 0.5 0.77+0.1250 40.76% 
 It is evident from Table No 7 and Graph G That the volume (ml) of Oedema in Group1(Control ) is 
1.3+0.04083, Group2 (Standard) 0.8+0.1732, Group 3 (J.K.125mg/Kg) 0.97+0.1031, Group 4 (J.K.250mg/Kg) 
0.92+0.0478 and Group 5 (J.K. 500mg/Kg) 0.77+0.1250. The results are statistically significant by ANOVA test. 
When compared with control group, Group 5 (J.K. 500mg/Kg) and Group 2 (Standard) showed more significant 
by multiple comparisons. 
  Table 8: Showing data of Anti-inflammatory activity after 24 hrs of carrageenin Injection 
Sr. 
No 
Group 1 Body 
Wt 
Drug and Dose Initial 
paw 
volume 
ml 
Final paw 
volume 
ml 
Oedema 
Vol. ml 
Mean 
Oedema 
Vol. ml/SEM. 
% 
Inhibition 
1 Control 133gms Saline water 
1ml/100gm body Wt. 
0.7 1.3 0.6   
2 Control 150gms Saline water 
1ml/100gm body Wt. 
0.9 1.6 0.7   
3 Control 140gms Saline water 
1ml/100gm body Wt. 
0.7 1.3 0.6   
4 Control 133gms Saline water 
1ml/100gm body Wt. 
0.7 1.3 0.6 0.62+0.0250 O% 
 Group 2 
5 Standard 137gms Ibuprofen100mg/Kg 0.9 1.4 0.5   
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Body Wt. 
6 Standard 145gms Ibuprofen100mg/Kg 
Body Wt. 
1.0 1.6 0.6   
7 Standard 140gms Ibuprofen100mg/Kg 
Body Wt. 
0.7 1.2 0.5   
8 Standard 147gms Ibuprofen100mg/Kg 
Body Wt. 
0.9 1.7 0.8 0.6+0.0707 3.22% 
 Group 3 
9 Trial (A) 130gm J.K. 125mg/Kg Body Wt 0.8 1.2 0.4   
10 Trial (A) 135gm J.K. 125mg/Kg Body Wt 0.7 1.2 0.5   
11 Trial (A) 148gm J.K. 125mg/Kg Body Wt 0.8 1.5 0.7   
12 Trial (A) 130gm J.K. 125mg/Kg Body Wt 0.8 1.6 0.8 0.6+0.0912 3.22% 
 Group 4 
13 Trial (B) 135gm J.K. 250mg/Kg Body Wt 0.7 1.3 0.6   
14 Trial (B) 140gm J.K. 250mg/Kg Body Wt 0.7 1.2 0.5   
15 Trial (B) 138gm J.K. 250mg/Kg Body Wt 0.8 1.3 0.5   
16 Trial (B) 140gm J.K. 250mg/Kg Body Wt 0.7 1.1 0.4 0.5+0.0408 19.35% 
 Group 5 
17 Trial (C) 140gms J.K. 500mg/Kg Body Wt 0.9 1.4 0.5   
18 Trial (C) 140gms J.K. 500mg/Kg Body Wt 0.8 1.4 0.6   
19 Trial (C) 139gms J.K. 500mg/Kg Body Wt 0.8 1.2 0.4   
20 Trial (C) 136gms J.K. 500mg/Kg Body Wt 0.8 1.1 0.3 0.45+0.0645 27.41% 
It is evident from Table No 7 and Graph I 
That the volume(ml) of Oedema in Group1 
(Control) is 0.62+0.0250, Group2 (Standard) 
0.6+0.0707, Group 3 (J.K.125mg/Kg) 0.6+0.0912, 
Group 4 (J.K.250mg/Kg 0.5+0.0408 and Group 5 
(J.K. 500mg/Kg) 0.45+0.0645 and the results are 
statistically insignificant by ANOVA test.  
DISCUSSION 
If we compare all the three doses of trial 
drug (Joints Kare), we conclude that J.K. 
500mg/kg Body wt has more activity in all 1,2,3,4 
and 24 hrs after carrageenin injection, even it 
shows higher effectively than the Standard 
(Ibuprofen).  
If we compare the J.K. 500mg/kg with 
Standard (Ibuprofen) as graph L we find that 
pattern of effectively after 1,2,3,4 and 24 hours of 
above mentioned both groups are almost same 
which indicates that there may be a resemblance 
in mode of action in these two groups as 
Ibuprofen which is believed to work through 
inhibition of cyclooxygenase (COX), thus 
inhibiting prostaglandin synthesis. There are at 
least 2 variants of cyclooxygenase (COX-1 and 
COX-2). Ibuprofen inhibits both COX-1 and COX-2. 
It appears that it’s analgesic, antipyretic, and anti-
inflammatory activities are achieved principally 
through COX-1 inhibition; whereas COX-2 
inhibition is responsible for its unwanted effects 
on platelet aggregation and the GI mucosa.  
CONCLUSION 
Summarizing the above it is concluded 
that Joints Kare has showed its extreme utility or 
significance on the inflammation probably 
because of its excellent activity of inhibiting the 
both early released and late released mediators 
which is rarely seen in any anti-inflammatory 
formulation. The present study revealed that the 
Joints Kare showed better anti-inflammatory 
activity. The maximum activity was observed 
during first and second hr. and the results are 
significant and are comparable to standard 
Ibuprofen. The anti-inflammatory activity may be 
due to the inhibition of release of histamine, 
serotonin and kinins in first hour after the 
injection of carrageenan, and this also retarded 
the release of prostaglandin like late phase 
mediators showing anti-inflammatory potential of 
Joints Kare. 
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